Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.2 USD | +0.48% |
|
-3.17% | -24.24% |
30/04 | Global markets live: Adidas, Mercedes, McDonalds, Eli Lilly, PayPal, MicroStrategy, Tesla... | ![]() |
30/04 | Transcript : Straumann Holding AG, Q1 2024 Sales/ Trading Statement Call, Apr 30, 2024 |
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- With an expected P/E ratio at 36.93 and 30.3 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-24.24% | 19.49B | - | ||
-0.07% | 18.18B | A | ||
+7.62% | 14.45B | B | ||
+3.65% | 9.82B | B- | ||
-21.91% | 1.92B | - | ||
+1.64% | 1.65B | B+ | ||
+4.60% | 1.32B | D- | ||
+0.47% | 523M | - | ||
0.00% | 398M | - | - | |
+95.43% | 212M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- STMN Stock
- SAUHY Stock
- Ratings Straumann Holding AG